Current status of diagnosis and Mesenchymal stem cells therapy for acute pancreatitis
Abstract Acute pancreatitis (AP) is an acute gastrointestinal disorder that is the most common and requiring emergency hospitalization. Its incidence is increasing worldwide, thus increasing the burden of medical services. Approximately 20% of the patients develop moderate to severe necrotizing panc...
Main Authors: | Fahad Munir, Muhammad B. Jamshed, Numan Shahid, Syed A. Muhammad, Noor B. Ghanem, Zhang Qiyu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-11-01
|
Series: | Physiological Reports |
Subjects: | |
Online Access: | https://doi.org/10.14814/phy2.14170 |
Similar Items
-
Mesenchymal Stem Cell in Pancreatic Islet Transplantation
by: Serena Barachini, et al.
Published: (2023-05-01) -
Mesenchymal stem cells decrease blood–brain barrier permeability in rats with severe acute pancreatitis
by: Ronggui Lin, et al.
Published: (2019-06-01) -
Prospect of Mesenchymal Stem-Cell-Conditioned Medium in the Treatment of Acute Pancreatitis: A Systematic Review
by: Ke Pang, et al.
Published: (2023-08-01) -
Protective effect of placenta-derived mesenchymal stem cell transplantation against severe acute pancreatitis in rats
by: HUANG Qilin, et al.
Published: (2020-04-01) -
Differentiation of human bone marrow-derived mesenchymal stem cells into functional pancreatic beta cells
by: Ayla Eker Sariboyaci, et al.
Published: (2021-09-01)